De-min Yu

1.6k total citations
45 papers, 1.2k citations indexed

About

De-min Yu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, De-min Yu has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Cancer Research. Recurrent topics in De-min Yu's work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (6 papers). De-min Yu is often cited by papers focused on Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (6 papers). De-min Yu collaborates with scholars based in China, Australia and Greece. De-min Yu's co-authors include Chunjun Li, Lin Lv, Pei Yu, Min Ding, Hui Li, Qiu-Mei Zhang, Steven A. Krilis, Jingyun Zhang, Lijun Duan and Pei Yu and has published in prestigious journals such as Blood, PLoS ONE and Diabetes Care.

In The Last Decade

De-min Yu

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
De-min Yu China	18	407	367	182	180	160	45	1.2k
Julie Favre France	19	514 1.3×	372 1.0×	232 1.3×	355 2.0×	113 0.7×	39	1.4k
Wei-Jan Chen Taiwan	25	581 1.4×	349 1.0×	179 1.0×	631 3.5×	255 1.6×	55	1.7k
Meiping Guan China	25	751 1.8×	348 0.9×	266 1.5×	136 0.8×	352 2.2×	56	1.6k
Akira Mima Japan	26	542 1.3×	641 1.7×	306 1.7×	156 0.9×	75 0.5×	66	1.6k
Lin Yin China	16	410 1.0×	121 0.3×	172 0.9×	126 0.7×	77 0.5×	57	953
Robert G. Spanheimer United States	22	545 1.3×	582 1.6×	214 1.2×	161 0.9×	72 0.5×	44	1.4k
Hana Farhangkhoee Canada	14	313 0.8×	124 0.3×	203 1.1×	147 0.8×	95 0.6×	19	897
Zongji Zheng China	25	781 1.9×	209 0.6×	189 1.0×	156 0.9×	414 2.6×	42	1.5k
Oliver Adam Germany	17	541 1.3×	263 0.7×	282 1.5×	785 4.4×	158 1.0×	28	1.7k
Kirsten Riches‐Suman United Kingdom	19	378 0.9×	85 0.2×	195 1.1×	186 1.0×	180 1.1×	40	903

Countries citing papers authored by De-min Yu

Since Specialization

Citations

This map shows the geographic impact of De-min Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De-min Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De-min Yu more than expected).

Fields of papers citing papers by De-min Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De-min Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De-min Yu. The network helps show where De-min Yu may publish in the future.

Co-authorship network of co-authors of De-min Yu

This figure shows the co-authorship network connecting the top 25 collaborators of De-min Yu. A scholar is included among the top collaborators of De-min Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De-min Yu. De-min Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Min, Qianhua Fang, Qian Liu, et al.. (2019). Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway. Journal of Diabetes and its Complications. 33(4). 267–277. 29 indexed citations

Li, Chunjun, Bei Sun, Qianhua Fang, et al.. (2017). Saxagliptin Induces β-Cell Proliferation through Increasing Stromal Cell-Derived Factor-1α In Vivo and In Vitro. Frontiers in Endocrinology. 8. 326–326. 14 indexed citations

Gu, Shuyan, et al.. (2016). Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. PLoS ONE. 11(11). e0167190–e0167190. 12 indexed citations

Wang, Jie, et al.. (2016). C-reactive protein/oxidized low density lipoprotein/β2-glycoprotein I complexes induce lipid accumulation and inflammatory reaction in macrophages via p38/mitogen-activated protein kinase and nuclear factor-κB signaling pathways. Molecular Medicine Reports. 14(4). 3490–3498. 8 indexed citations

Li, Chunjun, Gunnar Norstedt, Pei Yu, et al.. (2015). Effects of a Macro-Nutrient Preload on Type 2 Diabetic Patients. Frontiers in Endocrinology. 6. 139–139. 10 indexed citations

Feng, Ping, De-min Yu, Liming Chen, et al.. (2015). Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients. Acta Pharmacologica Sinica. 36(2). 200–208. 25 indexed citations

Xu, Jun, et al.. (2014). Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice. BMC Cardiovascular Disorders. 14(1). 114–114. 7 indexed citations

Zhou, Saijun, Rui Chen, Lin Lv, et al.. (2014). Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling. Molecular Medicine Reports. 11(3). 2167–2172. 7 indexed citations

Li, Chunjun, Xiaojuan Liu, Qian Yu, et al.. (2014). Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents. Diabetology & Metabolic Syndrome. 6(1). 69–69. 30 indexed citations

10.

Liu, Hongyan, Saijun Zhou, Gareth Denyer, et al.. (2014). Reduced β-2-glycoprotein І inhibits hypoxia-induced retinal angiogenesis in neonatal mice through the vascular endothelial growth factor pathway. Molecular Medicine Reports. 11(2). 1025–1030. 6 indexed citations

11.

Li, Chunjun, Qian Yu, Pei Yu, et al.. (2014). Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients. Cardiovascular Diabetology. 13(1). 36–36. 73 indexed citations

12.

Wang, Weilin, Saijun Zhou, Chunjun Li, et al.. (2013). Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis. Lipids in Health and Disease. 12(1). 174–174. 13 indexed citations

13.

He, Yuan, De-min Yu, Saijun Zhou, et al.. (2012). The relative risk factors of diabetic retinopathy. 4(10). 601–606. 1 indexed citations

14.

Li, Chunjun, Jing Li, Qiu-Mei Zhang, et al.. (2012). Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Cardiovascular Diabetology. 11(1). 142–142. 58 indexed citations

15.

Giannakopoulos, Bill, Lu Gao, Miao Qi, et al.. (2012). Factor XI is a substrate for oxidoreductases: Enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. Journal of Autoimmunity. 39(3). 121–129. 41 indexed citations

16.

Ioannou, Yiannis, Jingyun Zhang, Freda Passam, et al.. (2010). Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress–induced cell injury. Blood. 116(11). 1961–1970. 100 indexed citations

17.

Zhang, Qiumei, et al.. (2010). Improvement of insulin sensitivity by adding on glimepiride in type 2 diabetes patients poorly controlled with sub-maximal insulin dose. Zhonghua neifenmi daixie zazhi. 26(12). 1031–1034. 1 indexed citations

18.

Yu, De-min. (2009). The association of adiponcetin gene polymorphism with insulin resistance and type 2 diabetes mellitus. 1 indexed citations

19.

Zheng, Miaoyan, De-min Yu, Baocheng Chang, et al.. (2009). Relevance between endogenous creatinine clearance rate and islet β-cell function in type 2 diabetic patients. Zhonghua neifenmi daixie zazhi. 25(5). 501–505. 1 indexed citations

20.

Yu, Pei, Freda Passam, De-min Yu, Gareth Denyer, & Steven A. Krilis. (2008). β2‐glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. Journal of Thrombosis and Haemostasis. 6(7). 1215–1223. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact